Clinical trial
Hydrogen Inhalation Therapy in Patients With Moderate Covid-19: Phase-1 Clinical Trial
NCT04633980 is registered in ClinicalTrials.gov with University Hospital, Grenoble as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Hydrogen Inhalation Therapy in Patients With Moderate Covid-19: Phase-1 Clinical Trial
- Lead sponsor
- University Hospital, Grenoble
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- December 1, 2020
- Completion date
- May 23, 2023
- Enrollment
- 12 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.